Strategic Partnerships Opportunity to co-promote and distribute related cardiovascular devices, as evidenced by the Aug 26 2026 Atrility Medical collaboration for the AtriAmp, suggesting a path to expand Aquadex reach through integrated care workflows and cross-sell to Atrility’s installed base.

Clinical Expansion Recent R&D leadership hire and ongoing participation in major cardiology events indicate a push to advance product capabilities and visibility in hospital networks; leverage this momentum to position Aquadex as a preferred fluid management solution in heart failure and critical illness care teams.

Product Modernization Software update to Aquadex SmartFlow in 2026 demonstrates active product iteration; align sales with hospital IT and clinicians on the benefits of latest software features for safety, efficiency, and remote support.

Geographic Reach Headquartered in the US with a wholly owned Ireland subsidiary; target international hospitals and clinical centers seeking compliant, region-specific fluid management solutions to broaden market coverage and diversify revenue streams.

Financial Levers With revenue in the lower mid range and substantial funding, there is room to discuss expanded procurement programs, favorable terms, and joint development opportunities to accelerate adoption in mid-sized health systems and new market segments.